Genetic associations with human longevity at the APOE and ACE loci (original) (raw)

References

1. Abbott, M.H., Murphy, E.A., Bolling, D.R. & Abbey, H. The familial component in longevity, a study of the offspring of nonagenarians II. Preliminary analysis of the completed study. Johns Hopkins med. J. 134, 1–16 (1974).
   CAS PubMed Google Scholar
2. Finch, C.E. Genetic influences on lifespan, mortality rates, and age-related diseases. In Longevity, senescence and the genome, p. 298–352 (University of Chicago Press, Chicago, 1990).
   Google Scholar
3. Schächter, F. & Cohen, D. Longevity: a new field for human genetics. Lifespan 4, 1–3 (1993).
   Google Scholar
4. Schächter, F., Cohen, D. & Kirkwood, T.B.L. Prospects for the genetics of human longevity.Human Genetics 91, 519–526 (1993).
   Article PubMed Google Scholar
5. Proust, J. et al. HLA and longevity. Tissue Antigens 19, 168–173 (1982).
   Article CAS PubMed Google Scholar
6. Takata, H., Ishii, T., Suzuki, M., Sekiguchi, S. & Iri, H. Influence of major histocompatibllity complex region genes on human longevity among Okinawan-Japanese centenarians and nonagenarians. Lancet ii, 824–826 (1987).
   Article Google Scholar
7. Hatton, F. & Michel, E. Les causes de mortalité en 1990. Insee première 196, mai 1992.
8. Zannis, I. et al. Proposed nomenclature of apoE isoproteins, apoE genotypes and phenotypes. J. lipid Res. 23, 911–914 (1982).
   CAS PubMed Google Scholar
9. Davignon, J., Gregg, R.E. & Sing, C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1–21 (1988).
   Article CAS PubMed Google Scholar
10. Van Bockxmeer, F.M. & Mamotte, C.D.S. Apolipoprotein ε4 homozygosity in young men with coronary heart disease. Lancet 340, 879–880 (1992).
    Article CAS PubMed Google Scholar
11. Eto, M., Watanabe, K. & Makino, I. Increased frequencies of apolipoprotein ε2 and ε4 alleles In patients with ischemic heart disease. Clin. Genet. 36, 183–188 (1989).
    Article CAS PubMed Google Scholar
12. Tiret, L. et al. Evidence, from combined segregation and linkage anylysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. hum. Genet. 51, 197–205 (1992).
    CAS PubMed PubMed Central Google Scholar
13. Cambien, F. et al. Deletion polymorphism in the gene coding for angiotensin-oonverting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641–644 (1992).
    Article CAS PubMed Google Scholar
14. Tiret, L. et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341, 991–992 (1993).
    Article CAS PubMed Google Scholar
15. Hixson, J.E. & Vernier, D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with _Hha_I. J. lipid Res. 31, 545–548 (1990).
    CAS PubMed Google Scholar
16. Rigat, B., Hubert, C., Corvol, P. & Soubrier, F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucl. Acids Res. 20, 1433 (1992).
    Article CAS PubMed PubMed Central Google Scholar
17. Bailleul, S. et al. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum. Hered. 43, 159–165 (1993).
    Article CAS PubMed Google Scholar
18. Boerwinkle, E., Lee, S.S., Butler, R., Schumaker, V.N. & Chan, L. Rapid typing of apolipoprotein BDNA polymorphisms by DNA amplification. Atherosclerosis 81, 225 (1990).
    Article CAS PubMed Google Scholar
19. Peacock, R. et al. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92, 151–164 (1992).
    Article CAS PubMed Google Scholar
20. Andrew, S. et al. Nonrandom association between Huntington disease and two loci separated by about 3 Mb on 4p16.3. Genomics 13, 301–311 (1992).
    Article CAS PubMed Google Scholar
21. Weber, J.L. & May, P.E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. hum. Genet. 44, 388–396 (1989).
    CAS PubMed PubMed Central Google Scholar
22. Fries, J.F. Aging, natural death and the compression of morbidity. New Engl. J. Med. 303, 130 (1980).
    Article CAS PubMed Google Scholar
23. Ordovas, J.M., Litwack-Klein, L., Wilson, P.W.F., Schaefer, M.M. & Schaefer, E.J. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J. lipid Res. 28, 371–380 (1987).
    CAS PubMed Google Scholar
24. Utermann, G., Steinmetz, A. & Weber, W. Genetic control of human apolipoprotein E polymorphism: comparison one- and two-dimensionai techniques of isoprotein analysis. Hum. Genet. 60, 344–351 (1982).
    Article CAS PubMed Google Scholar
25. Boemi, M. et al. Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia 36, 229–233 (1993).
    Article CAS PubMed Google Scholar
26. Jeunemaître, X., Lifton, R.P., Hunt, S.C., Williams, R.R. & Lalouel, J.M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet. 1, 72–75 (1992).
    Article PubMed Google Scholar
27. Ehlers, M.R.W. & Riordan, J.F. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 28, 5311–5313 (1989).
    Article CAS PubMed Google Scholar
28. Costerousse, O., Jaspard, E., Wei, L., Corvol, P. & Alhene-Gelas, F. The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans. J. cardiovasc. Pharmacol. 20 (suppl. 9), S10–S15 (1992).
    Article CAS PubMed Google Scholar
29. McGeer, E.G. & Singh, E.A. Angiotensin-converting enzyme in cortical tissue in Alzheimer's and some other neurological diseases. Dementia 3, 299–303 (1992).
    Google Scholar
30. Eisenlohr, L.C., Bacik, I., Bennink, J.R., Bernstein, K. & Yewdell, J.W. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 71, 963–972 (1992).
    Article CAS PubMed Google Scholar
31. Jorgensen, J.O.L. & Christiansen, J.S. Brave new senescence: GH therapy in adults. Lancet 341, 1247 (1993).
    Article CAS PubMed Google Scholar
32. Donald, J.A. et al. Linkage relationships of the gene for apolipoprotein CII with loci on chromosome 19. Hum. Genet. 69, 39–43 (1985).
    Article CAS PubMed Google Scholar
33. Strittmatter, W.J. et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. natn Acad. Sci. U.S.A. 90, 1977–1981 (1993).
    Article CAS Google Scholar
34. Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921–923 (1993).
    Article CAS PubMed Google Scholar
35. Skoog, I., Nilsson, L., Palmertz, B., Andreasson, L.A., Svanborg, A. A population-based study of dementia in 85-year-olds. New Engl. J. Med. 328, 153–158 (1993).
    Article CAS PubMed Google Scholar
36. Kirkwood, T.B.L. & Rose, M.R. Evolution of senescence: late survival sacrificed for reproduction. Phil. Trans. R. Soc. Lond. B 332: 15–24 (1991).
    Article CAS Google Scholar

Download references